2023 marked the fourth consecutive challenging year for medtech, following a boom from 2012 to 2019. Despite many advances, a value creation slowdown may force companies to make bold moves to reset their trajectories in response to investor skepticism and other macroeconomic headwinds. Since the September 2023 publication of its comprehensive report Medtech Pulse: Thriving in the next decade, McKinsey has spoken to more than 200 medtech executives. In this article, McKinsey draws from the insights and questions that emerged from those conversations and offers seven predictions about the evolving industry landscape in the coming year.
Read the full article: What to Expect from Medtech in 2024 //
Source: https://www.mckinsey.com/industries/life-sciences/our-insights/what-to-expect-from-medtech-in-2024